Unlike the parsimonious model with any-cause dementia as outcome, the AD-specific biomarker pTau181 was selected in addition to GFAP for the AD dementia parsimonious model, which had superior discrimination compared to the demographic only model (eTable 2). This evidence concerns the gene GFAP and Alzheimer disease.